| Stage | REYN | % of rev | FLO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $944M | 100.00% | $1.2B | 100.00% | FLO ×1.26 |
| Gross profit | $245M | 25.95% | $578M | 48.45% | FLO +22.5pp |
| Operating income | $138M | 14.62% | $68M | 5.71% | REYN +8.9pp |
| Pre-tax income | $116M | 12.29% | $54M | 4.55% | REYN +7.7pp |
| Net income | $89M | 9.43% | $41M | 3.41% | REYN +6.0pp |
| Stage | REYN | FLO | Gap · A − B |
|---|---|---|---|
| Revenue | $944M100.00% | $1.2B100.00% | FLO ×1.26 |
| Gross profit | 25.95%$245M | 48.45%$578M | FLO +22.5pp |
| Operating income | 14.62%$138M | 5.71%$68M | REYN +8.9pp |
| Pre-tax income | 12.29%$116M | 4.55%$54M | REYN +7.7pp |
| Net income |
| 9.43%$89M |
| 3.41%$41M |
| REYN +6.0pp |
No shared counterparties.